Hollie Jackson - Concepedia

Author

Hollie Jackson

Also Known As

H Jackson, H. A. Jackson, H. Jackson, H.A. Jackson, Hollie A Jackson, Hollie A. Jackson, Hollie A. Jackson -, Hollie Jackson

Publications

1.3K

Citations

H-Index

Concepts

All Affiliations

Children's Hospital of Los Angeles University of Southern California University of California, San Francisco Children's Hospital of Pittsburgh Children's Hospital of Philadelphia

About

Hollie Jackson is an author at Children's Hospital of Los Angeles specializing in medicine, radiology, and neuroscience.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	5	5	94
2	Health Sciences	2	2	110
3	Engineering	1	1	13
4	Natural Sciences	1	1	21
5	Anatomy	1	1	34

Hollie Jackson

Publications

1.2K

Citations

H-Index

Page 1

	Year	Citations
Iodine-131—Metaiodobenzylguanidine Double Infusion With Autologous Stem-Cell Rescue for Neuroblastoma: A New Approaches to Neuroblastoma Therapy Phase I Study Katherine K. Matthay, Alekist Quach, John P. Huberty, Journal of Clinical Oncology	2009	118
Comparison of Iodine-123 Metaiodobenzylguanidine (MIBG) Scan and [<sup>18</sup>F]Fluorodeoxyglucose Positron Emission Tomography to Evaluate Response After Iodine-131 MIBG Therapy for Relapsed Neuroblastoma Denah R. Taggart, Myo Han, Alekist Quach, Journal of Clinical Oncology	2009	100
131I-Metaiodobenzylguanidine with Intensive Chemotherapy and Autologous Stem Cell Transplantation for High-Risk Neuroblastoma. A New Approaches to Neuroblastoma Therapy (NANT) Phase II Study Gregory A. Yanik, Judith G. Villablanca, John M. Maris, Biology of Blood and Marrow Transplantation	2015	93
Phase II Study of Oral Capsular 4-Hydroxyphenylretinamide (4-HPR/Fenretinide) in Pediatric Patients with Refractory or Recurrent Neuroblastoma: A Report from the Children's Oncology Group Judith G. Villablanca, Wendy B. London, Arlene Naranjo, Clinical Cancer Research	2011	92
Phase I trial of fenretinide delivered orally in a novel organized lipid complex in patients with relapsed/refractory neuroblastoma: A report from the new approaches to neuroblastoma therapy (NANT) consortium Barry J. Maurer, Min H. Kang, Judith G. Villablanca, Pediatric Blood & Cancer	2013	86
Phase I Trial of Oral Irinotecan and Temozolomide for Children With Relapsed High-Risk Neuroblastoma: A New Approach to Neuroblastoma Therapy Consortium Study Lars M. Wagner, Judith G. Villablanca, Clinton F. Stewart, Journal of Clinical Oncology	2009	78
Differential Computed Tomographic Attenuation of Metabolically Active and Inactive Adipose Tissues Sandra Chung, Krishna S. Nayak, Hollie Jackson, Journal of Computer Assisted Tomography	2011	75
Functional Brown Adipose Tissue is Related to Muscle Volume in Children and Adolescents Vicente Gilsanz, Sandra Chung, Hollie Jackson, The Journal of Pediatrics ObesityMetabolic SyndromeChildhood ObesityBody CompositionKinesiology	2010	73
Phase I Study of Vorinostat as a Radiation Sensitizer with 131I-Metaiodobenzylguanidine (131I-MIBG) for Patients with Relapsed or Refractory Neuroblastoma Steven G. DuBois, Susan Groshen, Julie R. Park, Clinical Cancer Research	2015	69
Dose Escalation Study of No-Carrier-Added <sup>131</sup>I-Metaiodobenzylguanidine for Relapsed or Refractory Neuroblastoma: New Approaches to Neuroblastoma Therapy Consortium Trial Katherine K. Matthay, Brian Weiss, Judith G. Villablanca, Journal of Nuclear Medicine	2012	63

Page 1